CV5 PHARMACOECONOMIC EVALUATION OF SIMVASTATIN VERSUS “NO TREATMENT” IN PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART DISEASE (CHD) IN POLAND
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63187-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)63187-7/fulltext
Section Title :
Section Order :
39
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63187-7&doi=10.1016/S1098-3015(10)63187-7